Dyne Therapeutics, Inc. (DYN) Stock Overview
Explore Dyne Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Dyne Therapeutics, Inc. (DYN)
Key Financials
Key Financials
Market Cap
4.8B
P/E Ratio
-7.69
EPS (TTM)
$-3.22
ROE
-0.64%
DYN Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Dyne Therapeutics, Inc. (NASDAQ: DYN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Dyne Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of DYN on the NASDAQ shows an RSI of 57.98, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $18.30 for the NASDAQ listing.
Key metrics behind Dyne Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -7.69 and a market capitalization of 4.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DYN on the NASDAQ.